Breaking News, Financial News

3Q Financial Report: AMRI

AMRI

3Q Revenues: $44.2 million (flat)

3Q Earnings: $1.4 million (-68%)

YTD Revenues: $133.2 million (-8%)

YTD Earnings: $2.9 million (-83%)

Comments: Total contract revenue for the quarter was $37.9 million, up 20%. Contract revenue for discovery services was $10.0 million, up 61%. Contract revenue from development and small scale manufacturing in the quarter was $9.6 million, up 45%. Large scale manufacturing revenues were $18.2 million, down 2%. Results for the quarter and YTD reflect a reduction in Allegra royalties, as well as the effects on large scale manufacturing due to the discontinuation of one product supplied to GE Healthcare in 2005.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters